Some semaglutide users go entire days eating one small meal
It was approved in 1959, making it the oldest FDA-approved weight-loss medication still on the market, and has traditionally been the most commonly prescribed anti-obesity drug in the United States, according to the Obesity Medicine Association
Henry Meds: Treatment options and medication prices are similar to Shed, though it does offer $100 off the first month and includes liraglutide in its treatment list
It does not replace meal planning, physical activity, glucose checks, or other parts of a diabetes plan
A GLP-1/glucagon agonist helps treat alcohol use disorder In a phase 2 trial, Altimmunes GLP-1/glucagon receptor co-agonist, pemvidutide, reduced heavy-drinking days and increased abstinence in patients with alcohol use disorder